United Biomedical, Inc.
http://unitedbiomedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From United Biomedical, Inc.
Aurobindo Announces Surprise Deal As COVID-19 Vaccine Progresses
While its COVID-19 vaccine, partnered with US-based Vaxxinity, is set to move to Phase III trials, Aurobindo has acquired an animal health company as well as several ANDAs and OTC assets. The acquisition and a deceleration in US sales caught analysts by surprise.
Aurobindo’s Animal Health Acquisition, US Deceleration Surprise Analysts
While its COVID-19 vaccine, partnered with US-based Vaxxinity, is set to move to Phase III trials, Aurobindo has acquired an animal health company as well as several ANDAs and OTC assets. The acquisition and a deceleration in US sales caught analysts by surprise.
H1 Approvals Seen For Russian, Novavax COVID-19 Vaccines In India
Multiple COVID-19 vaccines, including from RDIF and Novavax, could get accelerated approvals in India in the first half of calendar 2021, expanding the range at the country’s disposal. J&J's vaccine is expected to follow although it still hasn’t begun local trials, while Pfizer has temporarily withdrawn an application.
Aurobindo Expects Interim Phase II/III COVID-19 Vaccine Data By July
Aurobindo expects the first data readouts from the Phase II/III clinical trials of its partnered COVID-19 vaccine by July. While making progress in biosimilars development, the Indian company also plans to invest substantially in new API capacity.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
- Other Names / Subsidiaries
-
- UBI
- UBI Asia (UBIA)
- United BioPharma
- United Neuroscience
- COVAXX, Vaxxinity, Inc.